KR20020087045A - Ｃ형 간염 치료제 - Google Patents
Ｃ형 간염 치료제 Download PDFInfo
- Publication number
- KR20020087045A KR20020087045A KR1020027005739A KR20027005739A KR20020087045A KR 20020087045 A KR20020087045 A KR 20020087045A KR 1020027005739 A KR1020027005739 A KR 1020027005739A KR 20027005739 A KR20027005739 A KR 20027005739A KR 20020087045 A KR20020087045 A KR 20020087045A
- Authority
- KR
- South Korea
- Prior art keywords
- patients
- ukline
- ifn
- hepatitis
- chc
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA481/2000 | 2000-03-22 | ||
| AT0048100A AT408719B (de) | 2000-03-22 | 2000-03-22 | Mittel zur behandlung von hepatitis c |
| PCT/AT2001/000076 WO2001070203A2 (de) | 2000-03-22 | 2001-03-20 | Mittel zur behandlung von hepatitis c, enthaltend ukrain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20020087045A true KR20020087045A (ko) | 2002-11-21 |
Family
ID=3674939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020027005739A KR20020087045A (ko) | 2000-03-22 | 2001-03-20 | Ｃ형 간염 치료제 |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JP2003527414A (zh) |
| KR (1) | KR20020087045A (zh) |
| CN (1) | CN1416347A (zh) |
| AT (1) | AT408719B (zh) |
| AU (1) | AU2001239000A1 (zh) |
| BG (1) | BG107088A (zh) |
| BR (1) | BR0107211A (zh) |
| CA (1) | CA2389173A1 (zh) |
| EA (1) | EA200200584A1 (zh) |
| HR (1) | HRP20020367A2 (zh) |
| IL (1) | IL149314A0 (zh) |
| IS (1) | IS6360A (zh) |
| MA (1) | MA25509A1 (zh) |
| MX (1) | MXPA02004993A (zh) |
| NO (1) | NO20022253D0 (zh) |
| PL (1) | PL365000A1 (zh) |
| WO (1) | WO2001070203A2 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH695417A5 (de) * | 2001-11-15 | 2006-05-15 | Ddr Wassyl Nowicky Dipl Ing | Verfahren zur Umsetzung von Alkaloiden. |
| EP1459753A1 (en) | 2003-03-18 | 2004-09-22 | Nowicky, Wassyl, Dipl.-Ing. DDr. | Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments |
| WO2008039179A1 (en) * | 2006-09-26 | 2008-04-03 | Addiction Research Institute, Inc. | Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c |
| CN106343303A (zh) * | 2015-07-13 | 2017-01-25 | 张如安 | 灭杀乙肝病毒的饮料 |
| CN106109538A (zh) * | 2016-07-29 | 2016-11-16 | 桂林淮安天然保健品开发有限公司 | 治疗丙肝的药物组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3128018A1 (de) * | 1981-07-13 | 1983-04-07 | Wassyl 1060 Wien Nowicky | "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze" |
| US4970212A (en) * | 1982-05-18 | 1990-11-13 | Nowicky Wassili | Method of treating human illnesses which compromise the ability to mount an effective immunological response |
| US4816462A (en) * | 1982-05-18 | 1989-03-28 | Nowicky Wassili | Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds |
| PT93772A (pt) * | 1989-04-17 | 1991-01-08 | Searle & Co | Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer |
-
2000
- 2000-03-22 AT AT0048100A patent/AT408719B/de not_active IP Right Cessation
-
2001
- 2001-03-20 CA CA002389173A patent/CA2389173A1/en not_active Abandoned
- 2001-03-20 WO PCT/AT2001/000076 patent/WO2001070203A2/de active Application Filing
- 2001-03-20 BR BR0107211-0A patent/BR0107211A/pt not_active IP Right Cessation
- 2001-03-20 PL PL01365000A patent/PL365000A1/xx not_active Application Discontinuation
- 2001-03-20 JP JP2001568401A patent/JP2003527414A/ja active Pending
- 2001-03-20 AU AU2001239000A patent/AU2001239000A1/en not_active Abandoned
- 2001-03-20 IL IL14931401A patent/IL149314A0/xx unknown
- 2001-03-20 EA EA200200584A patent/EA200200584A1/ru unknown
- 2001-03-20 CN CN01803046A patent/CN1416347A/zh active Pending
- 2001-03-20 KR KR1020027005739A patent/KR20020087045A/ko not_active Application Discontinuation
- 2001-03-20 MX MXPA02004993A patent/MXPA02004993A/es unknown
-
2002
- 2002-04-24 IS IS6360A patent/IS6360A/is unknown
- 2002-04-26 HR HR20020367A patent/HRP20020367A2/hr not_active Application Discontinuation
- 2002-05-10 NO NO20022253A patent/NO20022253D0/no unknown
- 2002-05-28 MA MA26657A patent/MA25509A1/fr unknown
- 2002-09-12 BG BG107088A patent/BG107088A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL365000A1 (en) | 2004-12-27 |
| MXPA02004993A (es) | 2003-10-14 |
| IS6360A (is) | 2002-04-24 |
| WO2001070203A2 (de) | 2001-09-27 |
| ATA4812000A (de) | 2001-07-15 |
| NO20022253L (no) | 2002-05-10 |
| JP2003527414A (ja) | 2003-09-16 |
| WO2001070203A3 (de) | 2002-09-06 |
| HRP20020367A2 (en) | 2004-02-29 |
| IL149314A0 (en) | 2002-11-10 |
| AU2001239000A1 (en) | 2001-10-03 |
| MA25509A1 (fr) | 2002-07-01 |
| NO20022253D0 (no) | 2002-05-10 |
| BG107088A (en) | 2003-05-30 |
| AT408719B (de) | 2002-02-25 |
| EA200200584A1 (ru) | 2003-06-26 |
| BR0107211A (pt) | 2004-01-06 |
| CN1416347A (zh) | 2003-05-07 |
| CA2389173A1 (en) | 2001-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6007805A (en) | Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver | |
| TW593336B (en) | Low-toxicity human interferon-alpha analog | |
| EP1087778B1 (en) | Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c | |
| CN1094642A (zh) | 治疗组合物 | |
| KR20060120037A (ko) | Ｈｃｖ 감염 치료용 병용 요법 | |
| JP2017514911A (ja) | デルタ型肝炎ウイルス感染の処置 | |
| KR20020087045A (ko) | Ｃ형 간염 치료제 | |
| EP0627930A1 (en) | Composition and method of treating hepatitis b | |
| WO1994001125A9 (en) | Composition and method of treating hepatitis b | |
| EP3226973A2 (en) | Treatment of hepatitis delta virus infection | |
| WO1994022307A1 (en) | Suppresion of hiv expression by organic thiophosphate | |
| WO1988009673A1 (en) | Treatment of chronic type b hepatitis with a combination of recombinant human alpha and gamma interferons | |
| JPH02184632A (ja) | 医薬組成物 | |
| Shiga et al. | Chronic inflammatory demyelinating polyneuropathy due to the administration of pegylated interferon α-2b: a neuropathology case report | |
| Zeidner et al. | Treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) with controlled release capsular implantation of 2′, 3′-dideoxycytidine | |
| AU656574B2 (en) | Complexes of polyadenylic acid with polyuridylic acid | |
| AU2006281498A1 (en) | PEG-IFN alpha and ribavirin for HBV treatment | |
| KR0126677B1 (ko) | 항바이러스성 약제학적 조성물 | |
| WO1991004047A1 (en) | Synergistic effect of human recombinant interferon-beta on halogenated pyrimidines | |
| AU716760B2 (en) | Aids therapeutic composition | |
| Kunder et al. | Role of NK cells in immunomodulator-mediated resistance to herpesvirus infection | |
| US20030031647A1 (en) | IFN-alpha and amantadine for treating hepatitis C | |
| AU2003234637B2 (en) | Methods and compositions for inhibiting HIV replication | |
| Zhao et al. | Interferon-α neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-αn3 | |
| MXPA00011665A (en) | Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |